47 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Treatment • Invasive pulmonary ... • Aspergillus infections ... of eye Infectious ... Aspergillosis #Treatment #management ... #pharmacology #
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
patients with Opportunistic ... Infections • ... Pulmonary TB and ... count <50 • Pulmonary ... #Infections #management
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... of mode of HIV infection ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Surgical Wound Infection Algorithm
Algorithm for the management and treatment of surgical site infections (SSIs). 
*For
Algorithm Algorithm ... for the management ... susceptibility tests ... #Algorithm #IDSA ... #management #SSIs
Antibiotics for Intraabdominal Infection. 
Use your local antimicrobial susceptibility data for selecting the best empiric treatment!
Intraabdominal Infection ... selecting the best ... intra-abdominal infections ... infectiousdiseases #management ... #pharmacology #
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #Algorithm #treatment ... #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
. tuberculosis infections ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Tuberculin skin test ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
. tuberculosis infections ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Tuberculin skin test ... TB #Diagnosis #Management